Literature DB >> 30116542

Revisiting the evolution of tuberculosis therapy: historical reflections in the modern era.

Ahmed A Kolkailah1, Setri Fugar1, Juan Rey-Mendoza1, Tania Campagnoli1, Sherene Fakhran2.   

Abstract

Management of tuberculosis (TB) has witnessed several changes over the past decades. While medical management is now the mainstay of therapy, surgical intervention was once the only treatment option physicians had to offer. We discuss some historical surgical procedures and take a quick glance at the evolution of TB therapy. We note the importance of adequate history-taking and the implications of what seemingly obsolete techniques may have in contemporary practice. We also highlight the re-emergence of surgical options in the modern era with the rise of multidrug-resistance.

Entities:  

Year:  2018        PMID: 30116542      PMCID: PMC6086088          DOI: 10.1093/omcr/omy055

Source DB:  PubMed          Journal:  Oxf Med Case Reports        ISSN: 2053-8855


INTRODUCTION

An incidentally discovered lung mass can be catastrophic news to patients. Malignancy usually tops the list of differentials and tissue diagnosis remains the gold-standard. A thorough history, in rare circumstances, may spare the patient invasive procedures.

CASE REPORT

An 86-year-old gentleman with a past medical history of chronic obstructive pulmonary disease, pulmonary tuberculosis (TB) diagnosed and treated in the 1950s, and localized prostate cancer presented to the hospital with a 3-day history of productive cough, shortness of breath, and wheezing. He denied any fevers, chills, chest pain, night sweats or unintentional weight loss. He had a 40-pack-year smoking history but quit over 40 years ago. On physical exam, he was afebrile with normal vital signs, except for noted tachypnea. Focused upper chest exam revealed a large, non-mobile, left supraclavicular globular mass visible under the skin. On lung auscultation, he had diffuse expiratory wheezing and bilateral basilar crackles with diminished breath sounds over the left upper lobe. Laboratory work-up was significant for an elevated white blood cell count of 20.6 K/μL with a left shift and normocytic anemia of 9.2 g/dL. A chest X-ray was notable for a large, partially calcified lung mass (Fig. 1). A chest CT-scan similarly demonstrated a large, peripherally calcified soft tissue mass in the left upper chest wall, with destruction of adjacent ribs (Fig. 2). Differential diagnoses at that point included osteosarcoma, metastatic prostate cancer and mesothelioma, among many other possibilities. A tissue biopsy was deemed necessary. However, we sought to obtain a more thorough history and on further probing, our patient reported that he had underwent surgery in the 1950s for TB.
Figure 1:

Chest X-ray notable for a large, partially calcified lung mass, measuring ~16.5 × 10 cm, projecting over the left lung apex and likely external to the lung parenchyma.

Figure 2:

CT-scan demonstrating a large, peripherally calcified soft tissue mass in the left upper chest wall, measuring 9.4 × 11.8 × 14.7 cm, with destruction of adjacent first to third ribs.

Chest X-ray notable for a large, partially calcified lung mass, measuring ~16.5 × 10 cm, projecting over the left lung apex and likely external to the lung parenchyma. CT-scan demonstrating a large, peripherally calcified soft tissue mass in the left upper chest wall, measuring 9.4 × 11.8 × 14.7 cm, with destruction of adjacent first to third ribs.

DISCUSSION

Historically, prior to the advent of anti-tuberculous medications, several surgical techniques were employed for treatment of cavitary lung TB, including artificial pneumothorax, lobectomy, wedge resection, phrenic nerve crushing and collapse therapies, comprising thoracoplasty and plombage [1-3]. Artificial pneumothorax techniques were first performed on rabbits in the 1820s by James Carson, a Liverpool physician-physiologist. The concept had been scrutinized thereafter until the 1880s, when Carlo Forlanini, an Italian physician, pioneered the technique in humans and was later nominated for the Nobel prize in Medicine [4]. These efforts, with the concept of depriving mycobacteria from oxygen, paved the road for collapse therapies, including thoracoplasty and plombage. Thoracoplasty involves surgical resection of one or more ribs, thereby actively forcing the diseased lobe to collapse and allowing rapid healing [1, 2]. Plombage, another form of collapse therapy, entails surgically creating a cavity under the upper chest wall ribs and insertion of an inert material into the pleural cavity. Different materials were used with resultant varying radiological findings [1, 2]. Plombage was practiced from the 1930s to the mid-1950s and became obsolete with the advent of potent anti-tuberculous medications [2]. The discovery of Streptomycin in 1944 with subsequent development of Rifampicin and other anti-TB medications in the 1960s radically transformed therapeutic protocols by minimizing the role of surgery and improving the prognosis of the disease [2, 5]. However, in areas with high prevalence of TB and with the emergence of multidrug-resistant (MDR) or extensively drug-resistant (XDR) TB strains, the use of surgical interventions has regained momentum in the modern era. These techniques remain as an adjunct to medical therapy when it does not provide complete cure [3, 5–9]. Although in specific patients, surgery may provide superior results compared to medical therapy alone, careful case selection is warranted in addition to weighing the risks and hoped benefits of these surgical techniques, since they are not free from complications [1, 3, 6–9]. Indications for surgery include failure of medical therapy, localized lesions and MDR/XDR TB, provided adequate pulmonary reserve. The World Health Organization released a consensus report in 2014 on the role of surgery in the treatment of pulmonary TB, with a comprehensive summary of surgical indications and contraindications in contemporary practice [10].

CONCLUSION

Given the historical time frame, it is not unlikely that we would encounter similar cases among elderly patients in today’s practice. Based on the clinical history and imaging findings, our patient most likely underwent an upper-posterior extrapleural thoracoplasty, possibly combined with plombage. This case demonstrates how collapse therapy for pulmonary TB can mimic a mass lesion. A proper thorough history is always advisable.
  9 in total

1.  Extraperiosteal plombage in the treatment of pulmonary tuberculosis.

Authors:  F H YOUNG
Journal:  Thorax       Date:  1958-06       Impact factor: 9.139

Review 2.  Surgical treatment of drug-resistant tuberculosis.

Authors:  Russell R Kempker; Sergo Vashakidze; Nelly Solomonia; Nino Dzidzikashvili; Henry M Blumberg
Journal:  Lancet Infect Dis       Date:  2012-02       Impact factor: 25.071

3.  Revisiting an old therapy for tuberculosis.

Authors:  Don Hayes; Keith C Meyer; Hubert O Ballard
Journal:  Respir Care       Date:  2009-04       Impact factor: 2.258

4.  Untreatable tuberculosis: is surgery the answer?

Authors:  Masoud Dara; Giovanni Sotgiu; Richard Zaleskis; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2015-03       Impact factor: 16.671

5.  Surgical treatment of pulmonary tuberculosis: the phoenix of thoracic surgery?

Authors:  Luca Bertolaccini; Andrea Viti; Giovanni Di Perri; Alberto Terzi
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

Review 6.  Thoracoplasty for Tuberculosis in the Twenty-first Century.

Authors:  Denis Krasnov; Vladimir Krasnov; Dmitry Skvortsov; Irina Felker
Journal:  Thorac Surg Clin       Date:  2017-03-02       Impact factor: 1.750

7.  Carlo Forlanini, inventor of artificial pneumothorax for treatment of pulmonary tuberculosis.

Authors:  A Sakula
Journal:  Thorax       Date:  1983-05       Impact factor: 9.139

8.  Plombage in the 1980s.

Authors:  M P Shepherd
Journal:  Thorax       Date:  1985-05       Impact factor: 9.139

9.  Treatment of pulmonary tuberculosis: past and present.

Authors:  Dmitry Borisovich Giller; Boris Dmitrievich Giller; Galina Vitalievna Giller; Galina Vladimirovna Shcherbakova; Anuar Bahtibaevich Bizhanov; Inga Igorevna Enilenis; Aleksey Aleksandrovich Glotov
Journal:  Eur J Cardiothorac Surg       Date:  2018-05-01       Impact factor: 4.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.